4.5 Article

Mutations and Polymorphisms of the Skeletal Muscle α-Actin Gene (ACTA1)

Journal

HUMAN MUTATION
Volume 30, Issue 9, Pages 1267-1277

Publisher

WILEY
DOI: 10.1002/humu.21059

Keywords

skeletal muscle alpha-actin; ACTA1; congenital myopathies; locus-specific database

Funding

  1. Australian National Health and Medical Research Council (NHMRC) [403904, 403941]
  2. National Commissioning Group (NCG)
  3. NIH [R01 AR044345]
  4. Muscular Dystrophy Association (USA)
  5. The Joshua Frase Foundation
  6. Lee and Penny Anderson Family Foundation
  7. Medical Research Council [G0601943B] Funding Source: researchfish

Ask authors/readers for more resources

The ACTA1 gene encodes skeletal muscle alpha-actin, which is the predominant actin isoform in the sarcomeric thin filaments of adult skeletal muscle, and essential, along with myosin, for muscle contraction. ACTA1 disease-causing mutations were first described in 1999, when a total of 15 mutations were known. In this article we describe 177 different disease-causing ACTA1 mutations, including 85 that have not been described before. ACTA1 mutations result in five overlapping congenital myopathies: nemaline myopathy; intranuclear rod myopathy; actin filament aggregate myopathy; congenital fiber type disproportion; and myopathy with core-like areas. Mixtures of these histopathological phenotypes may be seen in a single biopsy from one patient. Irrespective of the histopathology, the disease is frequently clinically severe, with many patients dying within the first year of life. Most mutations are dominant and most patients have de novo mutations not present in the peripheral blood DNA of either parent. Only 10% of mutations are recessive and they are genetic or functional null mutations. To aid molecular diagnosis and establishing genotype-phenotype correlations, we have developed a locus-specific database for ACTA1 variations (http://waimr.uwa.edu.au). Hum Mutat 30:1267-1277, 2009. (C) 2009 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available